All news articles for March 2020

The latest action by industry on COVID-19

25-Mar-2020 By Ben Hargreaves

A rundown of the latest updates emerging from industry in response to the developing coronavirus pandemic.

Thermo Fisher to invest $475m into biopharma in 2020

25-Mar-2020 By Ben Hargreaves

Continuing a trend among larger CDMOs, Thermo Fisher reveals scale of investment into biopharma business and further focus on cell and gene therapy.

FDA roundup of COVID-19 responses

25-Mar-2020 By Jenni Spinner

The federal agency has been busy in recent weeks, taking actions and issuing advice in the face of the global coronavirus pandemic.

ProBioGen, Immunogenesis in cell line development agreement

24-Mar-2020 By Vassia Barba

Immunogenesis is tapping into ProBioGen’s manufacturing capabilities for its immuno-oncology lead candidate, as the potential treatment enters the clinic.

Once-monthly HIV regimen gets first regulatory approval

24-Mar-2020 By Vassia Barba

Health Canada marked the first positive nod to ViiV for its once-monthly HIV regimen, following rejection by the US FDA.

FDA lifts import alert on Ipca Labs for chloroquine supply

24-Mar-2020 By Ben Hargreaves

In order to boost the supply of chloroquine, the US FDA has allowed Ipca to supply APIs and finished product to the country.

WCG launches COVID-19 clinical research webinars

24-Mar-2020 By Jenni Spinner

The informational series, featuring guest panelists and company leaders, will focus on best practices in the face of the pandemic.

PolarisQB, Fujitsu partner on drug discovery

24-Mar-2020 By Jenni Spinner

The two companies are combining their technologies to speed the process of bringing to market treatments for Dengue fever and other diseases.

Data management tech aims to double COVID-19 testing capacity

24-Mar-2020 By Jenni Spinner

Technology company Ovation has launched an initiative involving its laboratory information management system designed to expand capacity nationwide.

Generics manufacturer prioritizes cardiac drugs amid shortages fears

23-Mar-2020 By Vassia Barba

Medivant to prioritize manufacturing of four generic drugs for cardiac diseases, amid fears of drug shortages due to COVID-19.

EMA calls to scale up COVID-19 trials for conclusive data

23-Mar-2020 By Vassia Barba

The agency says the industry should prioritize large randomized controlled studies developing COVID-19 treatments, to acquire robust data.

Trial management service available for free amid COVID-19 pandemic

23-Mar-2020 By Vassia Barba

Nubilaria joins a wave of providers that is offering their services for free to researchers working on potential treatments for COVID-19, with its ACTide EDC web platform.